These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27591351)

  • 1. Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta.
    Chuck AW; Thanh NX; Chari RS; Wilson RD; Janes-Kelley S; Wesenberg JC
    J Obstet Gynaecol Can; 2016 Jul; 38(7):659-666.e6. PubMed ID: 27591351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients.
    Skoll A; St Louis P; Amiri N; Delisle MF; Lalji S
    J Obstet Gynaecol Can; 2006 Mar; 28(3):206-213. PubMed ID: 16650359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labour.
    Dutta D; Norman JE
    J Obstet Gynaecol; 2010; 30(8):768-73. PubMed ID: 21126111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM; Liu E; Allenby K
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the fetal fibronectin test be used by remote dwelling pregnant women to predict the onset of labour at term and delay transfer for birth in regional settings?
    Rumbold A; Kruske S; Boyle J; Weckert R; Putland S; Giles L; Barclay L; Kildea S
    Rural Remote Health; 2013; 13(2):2126. PubMed ID: 23351083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the impact of fetal fibronectin test implementation on hospital admissions for preterm labour in Ontario: a multiple baseline time-series design.
    Fell DB; Sprague AE; Grimshaw JM; Yasseen AS; Coyle D; Dunn SI; Perkins SL; Peterson WE; Johnson M; Bunting PS; Walker MC
    BJOG; 2014 Mar; 121(4):438-46. PubMed ID: 24289187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD
    J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J; Chedraui P; Hidalgo L; Medina M
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of fetal fibronectin testing in twin pregnancies].
    Markova I; Nikolov A; Markov P
    Akush Ginekol (Sofiia); 2014; 53(6):4-8. PubMed ID: 25993735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the impact of introducing fetal fibronectin assay in the management of preterm labour at Middlemore Hospital, New Zealand.
    Musaad SM; Melson CL; Boswell DR
    Pathology; 2005 Jun; 37(3):226-30. PubMed ID: 16175896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved management in threatened preterm labour with rapid fetal fibronectin testing.
    Parry E; Singh TG; Dow D; Noovao F
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):240-1. PubMed ID: 16704480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year.
    Parisaei M; Currie J; O'Gorman N; Morris S; David AL
    J Obstet Gynaecol; 2016 Oct; 36(7):888-892. PubMed ID: 27147420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does availability of fetal firbonectin testing in the management of threatened preterm labour affect the utilization of hospital resources?
    Abenhaim HA; Morin L; Benjamin A
    J Obstet Gynaecol Can; 2005 Jul; 27(7):689-94. PubMed ID: 16100624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.